University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

Phase 2

Withdrawn

Conditions: Schizophrenia

Interventions: Drug: Org 24448
Other: Placebo

First Posted Date: 2007-01-23

Last Posted Date: 2016-02-09

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT00425815

Locations: 🇺🇸
Maryland Psychiatric Research Center, Catonsville, Maryland, United States
🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 5 locations

Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia

Phase 4

Completed

Conditions: Schizoaffective Disorder
Schizophrenia

Interventions: Drug: Placebos
Drug: modafinil

First Posted Date: 2007-01-18

Last Posted Date: 2017-09-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 33

Registration Number: NCT00423943

Locations: 🇺🇸
University of California Los Angeles School of Medicine, Los Angeles, California, United States

Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2006-12-07

Last Posted Date: 2009-05-04

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 36

Registration Number: NCT00408538

Locations: 🇺🇸
UCLA Center for HIV Prevention Research, Los Angeles, California, United States

Evaluating a Low-Literacy Discharge Medication Education Tool

Not Applicable

Completed

Conditions: Congestive Heart Failure
Coronary Artery Disease

Interventions: Other: Medication Education Tool

First Posted Date: 2006-12-07

Last Posted Date: 2008-01-25

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 287

Registration Number: NCT00408733

Locations: 🇺🇸
Los Angeles County/ USC Medical Center, Los Angeles, California, United States

Testosterone Treatment for Multiple Sclerosis

Phase 1

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Androgel 10 grams of gel containing 100 mg of testosterone

First Posted Date: 2006-11-30

Last Posted Date: 2019-11-22

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 10

Registration Number: NCT00405353

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Animal-Assisted Therapy for Hospitalized Heart Failure Patients

Not Applicable

Completed

Conditions: Heart Failure

First Posted Date: 2006-10-24

Last Posted Date: 2016-06-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 76

Registration Number: NCT00391456

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States

Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy

Phase 2

Completed

Conditions: Stroke

Interventions: Device: Merci Retriever and Penumbra System

First Posted Date: 2006-10-18

Last Posted Date: 2014-03-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 127

Registration Number: NCT00389467

Locations: 🇺🇸
University of California at Los Angeles, UCLA Stroke Network, 924 Westwood Blvd #300, Los Angeles, California, United States
🇺🇸
St. Louis University Hospital, 3635 Vista Avenue at Grand Boulevard Saint Louis, MO, St. Louis, Missouri, United States
🇺🇸
West Virginia University 1 Medical Center, Morgantown WV 26506, Morgantown, West Virginia, United States

and more 19 locations

The Effects of Probiotics in Atopic Dermatitis

Not Applicable

Withdrawn

Conditions: Atopic Dermatitis

First Posted Date: 2006-09-19

Last Posted Date: 2016-03-16

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT00378300

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States

Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability

Completed

Conditions: Rectal Health
Anorectal Symptomatology
Rectal Behaviors

First Posted Date: 2006-09-18

Last Posted Date: 2021-08-16

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 896

Registration Number: NCT00377221

Locations: 🇺🇸
AIDS Research Alliance, Los Angeles, California, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

A Study of Meditation as a Treatment for Epilepsy

Not Applicable

Completed

Conditions: Epilepsy

Interventions: Behavioral: Meditation

First Posted Date: 2006-09-01

Last Posted Date: 2016-07-22

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 8

Registration Number: NCT00370929

Locations: 🇺🇸
Geffen School of Medicine at UCLA, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy